Skip to main content
Clinical Trials/NCT03922698
NCT03922698
Unknown
Not Applicable

Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process

Neuromed IRCCS1 site in 1 country50 target enrollmentJune 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carotid Atherosclerosis
Sponsor
Neuromed IRCCS
Enrollment
50
Locations
1
Primary Endpoint
Characterization of the neuro-modulation of immune system in atherosclerosis
Last Updated
4 years ago

Overview

Brief Summary

The hypothesis of this study is that neural regulations of the atherosclerotic plaque, identified in the murine model of atherosclerosis, could also exist in human pathology. The dysregulation status of the autonomic nervous system is typical of several cardiovascular diseases, but the role it exerts in the modulation of important mechanisms at the basis of the atherosclerotic process progression has not been investigated yet. The main aim of this study will be to investigate, in the atherosclerotic plaque, the alterations of inflammatory and immune processes, the neural modulations and the presence of dysregulations of the autophagic process. The investigators will also associate the potential presence of neural modulations of the plaque to its stability/instability, from a clinical-translational point of view. Finally, the investigators aim at providing a solid basis for the development of novel therapeutic strategies, which could reduce the elevated health and welfare costs for the clinical management of cardiovascular pathologies such as atherosclerosis.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
June 30, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Neuromed IRCCS
Responsible Party
Principal Investigator
Principal Investigator

Giuseppe Lembo

Full Professor, MD, PhD

Neuromed IRCCS

Eligibility Criteria

Inclusion Criteria

  • age ≥ 45 and ≤ 90 years;
  • patients with severe (70-99%) carotid stenosis, diagnosed with color doppler echography or angio-MRI or angiography;
  • written informed consent.

Exclusion Criteria

  • carotid stenosis \<70% at carotid bifurcation or diagnosed with color doppler echography or angio-MRI or angiography;
  • severe neoplasia;
  • participation to other clinical trial, ongoing or terminated less than one month before enrolment in this study.

Outcomes

Primary Outcomes

Characterization of the neuro-modulation of immune system in atherosclerosis

Time Frame: At enrollment

Immunohistochemistry and immunofluorescence of the autonomic nervous and immune systems in the atherosclerotic plaque, and flow cytometry analysis of circulating immune cells.

Characterization of the autophagic process and correlation with neural modulations of the stability/instability plaque

Time Frame: At enrollment

Expression of autophagic markers and immunohistochemical analysis of the atherosclerotic plaque.

Study Sites (1)

Loading locations...

Similar Trials